Terlipressin

(Terlivaz®)

Terlipressin

Drug updated on 11/15/2023

Dosage FormInjection (intravenous; 0.85 mg/vial)
Drug ClassVasopressin receptor agonists
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Indicated to improve kidney function in adults with hepatorenal syndrome with rapid reduction in kidney function.